CI Stock Analysis: Buy, Sell, or Hold?
CI - The Cigna Group
$283.08
1.00 (0.35%)
▲
5d:
-3.66%
30d:
+0.38%
90d:
+8.26%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 30, 2026
Smart Money Accumulation
None View Scanner →
Strength: 7.5/10
Get Alerted When CI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CI shows positive signals but monitor for confirmation. Market pricing in 0.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: CI shows positive signals but monitor for confirmation. Market pricing in 0.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$403.09
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$250.29
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CI is currently trading at $283.08, which is considered fair relative to its 30-day fair value range of $278.25 to $292.46. The stock's valuation (Forward PE: 8.5) is in line with its historical norms (8.6). Remarkably, the market is currently pricing in an annual earnings decline of 0.5% over the next few years. This pessimistic expectation contrasts with the company's recent 29.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CI is in a downtrend. The price is currently testing key support at $279.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $340.50 (+20.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CI is in a downtrend. The price is currently testing key support at $279.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $340.50 (+20.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$278.25 -
$292.46
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.3% below Wall St target ($340.50)
Trading Range Analysis
30-Day Trading Range
$278.25 -
$292.46
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$279.20
Resistance Level
$299.27
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.46
Wall Street Target
$340.50
(+20.3%)
Revenue Growth (YoY)
4.6%
Earnings Growth (YoY)
29.1%
Profit Margin
2.3%
Valuation Discount vs History
-0.5% cheaper
PE vs Historical
8.5 vs 8.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.5%
(market-implied from PE analysis)
1-Year Target
$281.66
(-1%)
2-Year Target
$280.26
(-1%)
3-Year Target
$278.85
(-2%)
3-Yr Target (if PE normalizes)
(PE: 8→9)
$283.39
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.0%)
$970.70
(+243%)
Base:
(SPY PE: 8.5, Growth: 10.0%)
$377.15
(+33%)
Bear:
(PE: 7.2, Growth: 10.0%)
$320.58
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 11.96 | Current EPS (TTM): $23.58
Bull Case
$440.19
(+56%)
Analyst growth 41.9%, PE expands to 13.2
Base Case
$400.17
(+41%)
Market implied 41.9%, PE stable at 12.0
Bear Case
$191.81
(-32%)
Severe decline -20.0%, PE contracts to 10.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.5 to 8.6
Stabilization Target:
$287.68
(+1.6%)
PE Expansion Potential:
+1.6%
Share & Embed Analysis
Last updated: June 23, 2026 6:23 PM ET
Data refreshes hourly during market hours. Next update: 7:23 PM
Data refreshes hourly during market hours. Next update: 7:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CI showing a specific setup today?
Insider Activity (6 Months)
4
Buys
3
Sells
+
Net
INSIDERS SELLING
Recent Transactions
Gilbert Ray Cisneros, Jr.
SELL
2026-03-13
Everett Neville
SELL
1719 shares
2026-03-02
Nicole S Jones
SELL
2307 shares
2026-03-02
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$105 | 64 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$410 | 55 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$416 | 58 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$302 | 59 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$61 | 59 HOLD |
Advanced CI Option Strategies
Professional options setups generated by AI based on today's CI price and gamma walls.
